Onconetix Inc. (NASDAQ: ONCO)
$0.15
-0.0004 ( -0.27% ) 729.7K
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Market Data
Open
$0.15
Previous close
$0.15
Volume
729.7K
Market cap
$3.24M
Day range
$0.14 - $0.15
52 week range
$0.10 - $0.54
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 15, 2024 |
8-k | 8K-related | 16 | Jul 11, 2024 |
3 | Insider transactions | 1 | Jun 20, 2024 |
8-k/a | 8K-related | 14 | Jun 14, 2024 |
8-k | 8K-related | 14 | Jun 13, 2024 |
10-q | Quarterly Reports | 91 | May 20, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |
8-k | 8K-related | 13 | May 13, 2024 |
8-k | 8K-related | 15 | Apr 26, 2024 |
10-k | Annual reports | 122 | Apr 11, 2024 |